Evidence map›Paper›PMID 41294076›Full record

ArticleAnnals of neurology2026

Anatomical Progression of Neuropathology in FTLD-TDP Type C and Linkage to Annexin A11.

Allegra Kawles, Caroline Nelson, Ivan Ayala, Elena Barbieri, Rudolph Castellani, Changiz Geula, Tamar Gefen, M Marsel Mesulam

Abstract read
In one paragraph

Article in Annals of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Allegra KawlesMesulam Institute for Cognitive Neurology and Alzheimer's Disease and the Kathryn Aring Piper Center for Frontotemporal Cognitive Disorders, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID 0000-0003-3153-5350
Caroline NelsonMesulam Institute for Cognitive Neurology and Alzheimer's Disease and the Kathryn Aring Piper Center for Frontotemporal Cognitive Disorders, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Ivan AyalaMesulam Institute for Cognitive Neurology and Alzheimer's Disease and the Kathryn Aring Piper Center for Frontotemporal Cognitive Disorders, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Elena BarbieriMesulam Institute for Cognitive Neurology and Alzheimer's Disease and the Kathryn Aring Piper Center for Frontotemporal Cognitive Disorders, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID 0000-0002-7303-846X
Rudolph CastellaniMesulam Institute for Cognitive Neurology and Alzheimer's Disease and the Kathryn Aring Piper Center for Frontotemporal Cognitive Disorders, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Changiz GeulaMesulam Institute for Cognitive Neurology and Alzheimer's Disease and the Kathryn Aring Piper Center for Frontotemporal Cognitive Disorders, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Tamar GefenMesulam Institute for Cognitive Neurology and Alzheimer's Disease and the Kathryn Aring Piper Center for Frontotemporal Cognitive Disorders, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
M Marsel MesulamMesulam Institute for Cognitive Neurology and Alzheimer's Disease and the Kathryn Aring Piper Center for Frontotemporal Cognitive Disorders, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID 0000-0001-5731-851X

Funding

Neuropathology CoreP30AG013854 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VASSAR, ROBERT J · 1996 to 2020
$28.9M
Research Education Core FP30AG072977 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROBERT J VASSAR · 2021 to 2026
$26.3M
ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIAR01AG077444 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MAREK-MARSEL M MESULAM, EMILY J ROGALSKI · 2022 to 2026
$10.4M
PREDOCTORAL AND POSTDOCTORAL TRAINING PROGRAM IN AGING AND DEMENTIAT32AG020506 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROBERT J VASSAR, SANDRA WEINTRAUB · 2002 to 2026
$9.9M
Language in Primary Progressive AphasiaR01DC008552 · NIDCD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MESULAM, MAREK-MARSEL M · 2007 to 2021
$8.5M
Determinants of Neurodegenerative Decline in Primary Progressive AphasiaR01NS075075 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROGALSKI, EMILY J · 2012 to 2016
$1.7M
Anatomic, Pathologic, and Molecular Signatures of FTLD-TDP type CR01AG091388 · NIA · NORTHWESTERN UNIVERSITY · PI CHANGIZ GEULA, Tamar D Gefen · 2025 to 2026
$1.6M
Vulnerability Profiles of Comorbid Alzheimer and TDP-43 Proteinopathies in Amnestic DementiaR56AG075600 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GEFEN, TAMAR D · 2023 to 2023
$603k
Clinical, Anatomic, and Pathologic Spread of Semantic Language Impairment in the Type C Variant of Frontotemporal Lobar Degeneration due to TDP-43 (TDP-C)F31AG094137 · NIA · NORTHWESTERN UNIVERSITY · PI KAWLES, ALLEGRA · 2025 to 2025
$50k
NIA NIH HHS F31 AG094137NIA NIH HHS P30 AG013854NIA NIH HHS P30 AG072977NIA NIH HHS R01 AG077444NIA NIH HHS R01 AG091388NIA NIH HHS R56 AG075600NIA NIH HHS T32 AG020506NIDCD NIH HHS R01 DC008552NINDS NIH HHS R01 NS075075
6 · The paper itself

Abstract

objectiveFrontotemporal lobar degenerations (FTLD)-TDP type C (TDP-C) is distinguished from other FTLD-TDP subtypes by 3 unique features: (1) invariable onset in the anterior temporal lobe (ATL), (2) phosphorylated TDP-43 (pTDP) neurites in cortex, and (3) colocalization of all pTDP deposits with annexin A11 (ANXA11). This article provides a whole-brain anatomical account of TDP-C disease progression in relation to clinical, imaging, and neuropathologic patterns.

methodsThirty-two cases with TDP-C were studied, including neuropathologic findings and longitudinal magnetic resonance imaging. In 6 of these cases, cortical and subcortical areas were analyzed using whole hemisphere sections. Five control cases were used for comparison.

resultsProgression was reconstructed with the assumption that regions displaying more severe neurodegeneration at postmortem represented earlier onset sites, an assumption supported by longitudinal imaging. Four stages of cortical TDP-C neuropathology were identified. Subcortically, the fascia dentata contained dense round bodies of pTDP, which did not seem to cause neuronal loss. These deposits were also seen in the nucleus accumbens, islands of Calleja, and the nucleus of the stria terminalis. Cortical predilection sites had higher densities of neurites especially in cases without much tissue destruction. However, cases with more severe overall neurodegeneration displayed a paradoxical scarcity of pTDP deposits at predilection sites. Neurodegeneration patterns identified in whole-hemisphere cases were corroborated by 26 additional cases processed for neuropathologic diagnosis. All pTDP inclusions contained ANXA11. In control cases, the distribution of ANXA11-rich neurons was largely concordant with the pattern of susceptibility to TDP-C.

interpretationNeurodegeneration originates in upper cortical layers of ATL and spreads posteriorly along paralimbic mediodorsal and associative ventrolateral pathways. In normal cortex, nuclear TDP-43 is distributed throughout the cortex, whereas normal ANXA11 shows variations that largely mirror TDP-C predilection patterns. The possibility is raised that ANXA11 may be a factor in determining the distribution of TDP-C neurodegeneration. ANN NEUROL 2026;99:639-655.

Indexed as

AnnexinsBrainFrontotemporal Lobar DegenerationAgedAged, 80 and overDisease ProgressionDNA-Binding ProteinsFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedAnnexinsDNA-Binding ProteinsTARDBP protein, human

Identifiers

PMID41294076
PMCPMC12704552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.